Search Results - "Stosman, K. I."

Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses by Sivak, K. V., Stosman, K. I., Kalinina, E. Yu, Lyubishin, M. M., Orshanskaya, Ya. R., Savateeva-Lyubimova, T. N., Kazakova, S. B., Fedoseeva, D. M., Nazarov, A. S., Radion, E. I., Yudin, S. M., Keskinov, A. A., Makarov, V. V., Yudin, V. S., Zheltukhin, A. O., Vorobyev, P. O., Kochetkov, D. V., Ilyinskaya, G. V., Lipatova, A. V., Chumakov, P. M.

“…INTRODUCTION. Developing novel medicines based on non-pathogenic enterovirus strains exhibiting oncotropic and oncolytic properties represents an up-to-date…”
Get full text

The Effect of TLR4 Blockade on Some Indicators of Systemic Inflammatory Response to Proteus mirabilis LPS in Rats by Sivak, K. V., Stosman, K. I., Rassokha, T. A., Aleksandrov, A. G., Kuzmich, N. N., Orshanskaya, Ya. R., Savateeva-Lubimova, T. N., Lesiovskaya, E. E.

“…The effects of TLR4 blocker on blood cell morphology, concentrations proinflammatory cytokines, and functional state of the liver and kidneys were studied in…”
Get full text

Evaluation of Antiinflammatory Activity of 4'-О-Methylhonokiol Derivatives in a Neuroinflammation Model by Sivak, K. V., Stosman, K. I., Muzhikyan, A. A., Alexandrov, A. G., Viktorov, N. B., Vaulina, D. D., Gomzina, N. A.

“…The synthesis of two derivatives of lignan 4'- O -methylhonokiol ( MH ), i.e., 4'-methoxy-5-propyl-1,1'-biphenyl-2-ol ( III ) and…”
Get full text

Antinicrobial, antiexudative and immunotropic properties of chlorhexidine bigluconate in combination with zinc oxide, succinic and ascorbic acids by Savateeva-Liubimova, T N, Lesiovskaia, E E, Sivak, K V, Stosman, K I, Stroĭkova, G S, Rassokha, T A, Rudenko, L I

“…Optimal combination of chlorhexidine bigluconate with ascorbic acid, succinic acid, and zinc oxide was found as a result of comparative trials. The composition…”
Get more information

Preclinical study of Reamberin and Remaxol safety by Savateeva-Liubimova, T N, Lesiovskaia, E E, Sivak, K V, Stosman, K I, Shevchuk, M K, Dagaev, S G, Savateev, A V, Kovalenko, A L, Petrov, A Iu, Sukhanov, D S

“…Preclinical safety of reamberin, a preparation of succinic acid intended for the treatment of patients with shock conditions of different etiology, and remaxol…”
Get more information